Literature DB >> 25246291

Risk factors in diabetic nephropathy progression at present.

D Lizicarova, B Krahulec, E Hirnerova, L Gaspar, Z Celecova.   

Abstract

Diabetic nephropathy is becoming an increasingly important cause of morbidity and mortality worldwide as a consequence of increasing prevalence of type 2 diabetes and obesity. The glomeruli of patients with diabetes are characterized by glomerular hypertrophy, widening of the glomerular basement membrane, mesangial expansion, podocytopenia leading to nodular (Kimmelstiel-Wilson) glomerulosclerosis. Many studies have reported the initiation and progression of incipient nephropathy in type 1 diabetes patients, but only limited data are available in type 2 diabetes patients. The information on the risk factors and conversion rate of normal renal function to proteinuria in type 2 diabetes patients is sparse. In this report, we review risk factors of diabetic nephropathy progression in type 2 diabetes patients (Ref. 50).

Entities:  

Mesh:

Year:  2014        PMID: 25246291     DOI: 10.4149/bll_2014_101

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

1.  Protective effects of low-dose rapamycin combined with valsartan on podocytes of diabetic rats.

Authors:  Jin Zhang; Xiaozhou Hu; Shaoting Wang; Yan Zhang; Hong Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Study on the association between vitamin D receptor gene fokI (T/C) polymorphisms and the susceptibility to type 2 diabetic kidney disease of Han nationality in south of China.

Authors:  Xia Dong; Dan Yang; Rui Han; Wei Yang; Wei Pang; Dianping Song; Rou Shi
Journal:  Int J Mol Epidemiol Genet       Date:  2018-10-20

3.  Is type 2 diabetes mellitus another intercellular junction-related disorder?

Authors:  Carla B Collares-Buzato; Carolina Pf Carvalho
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-23

Review 4.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

5.  Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.

Authors:  Wenjie Tian; Hongen Lei; Ruili Guan; Yongde Xu; Huixi Li; Lin Wang; Bicheng Yang; Zhezhu Gao; Zhongcheng Xin
Journal:  Drug Des Devel Ther       Date:  2015-09-07       Impact factor: 4.162

6.  Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.

Authors:  Ruixuan Jiang; Ernest Law; Zhou Zhou; Hongbo Yang; Eric Q Wu; Raafat Seifeldin
Journal:  Diabetes Ther       Date:  2018-03-29       Impact factor: 2.945

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.